Portola Pharmaceuticals (PTLA) - NASDAQ
Company Description
Portola Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation. Its development-stage portfolio consists of the compounds including Betrixaban, a... More
Sector: Healthcare
Industry: Drug Related Products
Country: United States